Please be advised that the Sisters In Stride: Women's Gynecologic Cancer Awareness Walk, scheduled for Saturday, September 23 at 10 a.m., has been canceled due to the expected inclement weather.
January 18, 2023
The Valley Hospital, under the leadership of Rajiv Tayal, MD, Director of Cardiac Catheterization Laboratory and Structural Heart Program at The Valley Hospital, has become the first medical institution in the world to use Abiomed’s new Impella 14 Fr Low Profile Sheath during a high risk, complex, coronary stenting procedure.
Valley’s team of Interventional Cardiologists used the Impella 14 Fr Low Profile Sheath while implanting an Impella® CP with SmartAssist heart pump, which is designed to provide short-term blood flow support by helping to pump blood throughout the body. When implanted in the left ventricle, the Impella device takes over the pumping function of the heart, pumping oxygenated blood to tissues throughout the body while allowing the heart to rest and recover.
“Abiomed’s Impella Low Profile Sheath is designed to have a smaller footprint in the artery in which it is placed, making the insertion and removal of the Impella heart pump device easier while still allowing even the most complex procedures to be performed through a single access site in the body,” said Dr. Tayal. “The new sheath represents a tremendous step forward in advancing care and improving outcomes in patients requiring mechanical circulatory support for both high-risk percutaneous coronary intervention and cardiogenic shock.”
“Our team of interventionalists at the Valley Heart and Vascular Institute are pleased to be able to offer our patients personalized care using the latest leading-edge technology,” said Hussein Rahim, MD, interventional cardiologist and structural heart specialist.
For more information about heart care at Valley, please visit ValleyHealth.com/Heart.